Norman Gitlin

9.3k citations
101 papers · 7.7k · 5 hit papers · h-index 30

Impact in

  • Hepatology top 0.1%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Liver Diseases and Immunity
  • Epidemiology top 0.5%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 23
    • Liver Disease and Transplantation 13
    • Liver Diseases and Immunity 5
    • Liver Disease Diagnosis and Treatment 21
    • Hepatitis B Virus Studies 10

Norman Gitlin

95 papers receiving 7.4k citations

Norman Gitlin's Hit Papers

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 2019 · 1.1k citations
1.1k0+4+8Years since publication4008001.2k

Peers

Norman Gitlin
Comparison fields: 5 of 136
  • Hepatology 5.4k
  • Epidemiology 4.1k
  • Infectious Diseases 638
  • Pharmacology 224
  • Endocrinology, Diabetes and Metabolism 410
Replace Ricard Solà with:
Ricard Solà Spain
Marcello Persico Italy
Tobias Goeser Germany
Samuel Harold Sigal United States
Maurizio Pompili Italy
Adrian Carlos Gadano Argentina
Jee‐Fu Huang Taiwan
Harald Hofer Austria
Coleman I. Smith United States
Thierry Poynard France
Norman Gitlin relative to Ricard Solà Spain Ricard Solà's profile →
Citations per field
00.5×1.5×
Ricard Solà · 1×
Citations per year

Countries citing papers authored by Norman Gitlin

Since Specialization
Citations

This map shows the geographic impact of Norman Gitlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Gitlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Gitlin more than expected).

Fields of papers citing papers by Norman Gitlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Gitlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Gitlin. The network helps show where Norman Gitlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Norman Gitlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Norman Gitlin Line = papers co-authored together Norman Gitlin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Hit paper breakdown →
20141457
2
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Hit paper breakdown →
20141123
3
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Hit paper breakdown →
20191063
4
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
Hit paper breakdown →
2014664
5
All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study
Hit paper breakdown →
2015568
6 1998204
7 2004204
8 1986182
9 1999168
10 2016166
11 2017166
12 2010152
13 1982142
14 1997136
15
Ischemic hepatitis: widening horizons.
199290
16 200970
17 198262
18 202360
19
Splenic blood flow and resistance in patients with cirrhosis before and after portacaval anastomoses.
196956
20 201555

About Norman Gitlin

Norman Gitlin is a scholar working on Hepatology, Epidemiology, Surgery, Gastroenterology and Clinical Biochemistry, having authored 101 papers that have together received 7.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (23 papers), Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (13 papers), Hepatitis B Virus Studies (10 papers), Metabolism and Genetic Disorders (5 papers), Helicobacter pylori-related gastroenterology studies (5 papers), Liver Diseases and Immunity (5 papers) and Pleural and Pulmonary Diseases (4 papers). The work is most often cited by research in Hepatology (5.4k citations), Epidemiology (4.1k citations), Infectious Diseases (638 citations), Pharmacology (224 citations) and Endocrinology, Diabetes and Metabolism (410 citations). Norman Gitlin has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Mitchell L. Shiffman, Eugene R. Schiff, Louis Kreel, Sheila Sherlock, K. Rajender Reddy, John L. Stauffer, Lewis T. Mann, Harry S. Williams, Gordon R. Grahame and Ronald C. Silvestri. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, Current Opinion in Gastroenterology and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact